Composition for the treatment of cystic fibrosis

Details for Australian Patent Application No. 2010280684 (hide)

Owner SciPharm SaRL

Inventors Freissmuth, Michael; Koenig, Xaver; Gloeckel, Christina

Agent TJ IP Patents, Trade Marks & Designs

Pub. Number AU-A-2010280684

PCT Pub. Number WO2011/015630

Priority 09167491.1 07.08.09 EP

Filing date 5 August 2010

Wipo publication date 10 February 2011

International Classifications

A61K 31/557 (2006.01) - Eicosanoids, e.g. leukotrienes

A61K 31/5585 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

23 February 2012 PCT application entered the National Phase

  PCT publication WO2011/015630 Priority application(s): WO2011/015630

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010280688-Controlled release formulations of lipocalin muteins

2010280682-Novel antipathogenic peptides